- Home
- BHB vs MREO Comparison
BHB vs MREO Comparison
Compare BHB & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHB
- MREO
- Stock Information
- Founded
- BHB 1887
- MREO 2015
- Country
- BHB United States
- MREO United Kingdom
- Employees
- BHB N/A
- MREO N/A
- Industry
- BHB Major Banks
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- BHB Finance
- MREO Health Care
- Exchange
- BHB Nasdaq
- MREO Nasdaq
- Market Cap
- BHB 456.0M
- MREO 424.5M
- IPO Year
- BHB 1997
- MREO N/A
- Fundamental
- Price
- BHB $31.11
- MREO $2.32
- Analyst Decision
- BHB Hold
- MREO Strong Buy
- Analyst Count
- BHB 2
- MREO 7
- Target Price
- BHB $33.00
- MREO $7.71
- AVG Volume (30 Days)
- BHB 39.1K
- MREO 1.5M
- Earning Date
- BHB 04-17-2025
- MREO 05-13-2025
- Dividend Yield
- BHB 4.10%
- MREO N/A
- EPS Growth
- BHB 3.26
- MREO N/A
- EPS
- BHB 2.84
- MREO N/A
- Revenue
- BHB $149,882,000.00
- MREO N/A
- Revenue This Year
- BHB $18.22
- MREO N/A
- Revenue Next Year
- BHB $13.38
- MREO $56.11
- P/E Ratio
- BHB $11.00
- MREO N/A
- Revenue Growth
- BHB 1.63
- MREO N/A
- 52 Week Low
- BHB $24.48
- MREO $1.58
- 52 Week High
- BHB $38.47
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- BHB 60.40
- MREO 46.49
- Support Level
- BHB $29.40
- MREO $2.28
- Resistance Level
- BHB $31.72
- MREO $2.75
- Average True Range (ATR)
- BHB 0.83
- MREO 0.17
- MACD
- BHB 0.22
- MREO -0.01
- Stochastic Oscillator
- BHB 83.06
- MREO 12.24
About BHB Bar Harbor Bankshares Inc.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. The company has following reportable segments such as Commercial construction, Commercial real estate owner occupied and non-owner occupied, Tax Exempt, Commercial and industrial loans, Residential real estate, Home equity and Consumer other. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, and fiduciary services, investment planning, education funding, individual retirement planning..
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).